Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Cell Therapy Product Introduction
1.2 Global Cell Therapy Market Size Forecast (2020-2031)
1.3 Cell Therapy Market Trends & Drivers
1.3.1 Cell Therapy Industry Trends
1.3.2 Cell Therapy Market Drivers & Opportunity
1.3.3 Cell Therapy Market Challenges
1.3.4 Cell Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell Therapy Players Revenue Ranking (2024)
2.2 Global Cell Therapy Revenue by Company (2020-2025)
2.3 Key Companies Cell Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell Therapy
2.6 Cell Therapy Market Competitive Analysis
2.6.1 Cell Therapy Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Cell Therapy Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stem Cell
3.1.2 Non-Stem Cell
3.2 Global Cell Therapy Sales Value by Type
3.2.1 Global Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cell Therapy Sales Value, by Type (2020-2031)
3.2.3 Global Cell Therapy Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Cell Therapy Sales Value by Application
4.2.1 Global Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cell Therapy Sales Value, by Application (2020-2031)
4.2.3 Global Cell Therapy Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Cell Therapy Sales Value by Region
5.1.1 Global Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cell Therapy Sales Value by Region (2020-2025)
5.1.3 Global Cell Therapy Sales Value by Region (2026-2031)
5.1.4 Global Cell Therapy Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Cell Therapy Sales Value, 2020-2031
5.2.2 North America Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Cell Therapy Sales Value, 2020-2031
5.3.2 Europe Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Cell Therapy Sales Value, 2020-2031
5.4.2 Asia Pacific Cell Therapy Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Cell Therapy Sales Value, 2020-2031
5.5.2 South America Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell Therapy Sales Value, 2020-2031
5.6.2 Middle East & Africa Cell Therapy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cell Therapy Sales Value, 2020-2031
6.3 United States
6.3.1 United States Cell Therapy Sales Value, 2020-2031
6.3.2 United States Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cell Therapy Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cell Therapy Sales Value, 2020-2031
6.4.2 Europe Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cell Therapy Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cell Therapy Sales Value, 2020-2031
6.5.2 China Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cell Therapy Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cell Therapy Sales Value, 2020-2031
6.6.2 Japan Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cell Therapy Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cell Therapy Sales Value, 2020-2031
6.7.2 South Korea Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cell Therapy Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cell Therapy Sales Value, 2020-2031
6.8.2 Southeast Asia Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cell Therapy Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cell Therapy Sales Value, 2020-2031
6.9.2 India Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cell Therapy Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Profile
7.1.2 Gilead Sciences Main Business
7.1.3 Gilead Sciences Cell Therapy Products, Services and Solutions
7.1.4 Gilead Sciences Cell Therapy Revenue (US$ Million) & (2020-2025)
7.1.5 Gilead Sciences Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis Cell Therapy Products, Services and Solutions
7.2.4 Novartis Cell Therapy Revenue (US$ Million) & (2020-2025)
7.2.5 Novartis Recent Developments
7.3 Osiris
7.3.1 Osiris Profile
7.3.2 Osiris Main Business
7.3.3 Osiris Cell Therapy Products, Services and Solutions
7.3.4 Osiris Cell Therapy Revenue (US$ Million) & (2020-2025)
7.3.5 Osiris Recent Developments
7.4 Vericel Corporation
7.4.1 Vericel Corporation Profile
7.4.2 Vericel Corporation Main Business
7.4.3 Vericel Corporation Cell Therapy Products, Services and Solutions
7.4.4 Vericel Corporation Cell Therapy Revenue (US$ Million) & (2020-2025)
7.4.5 Vericel Corporation Recent Developments
7.5 Vcanbio
7.5.1 Vcanbio Profile
7.5.2 Vcanbio Main Business
7.5.3 Vcanbio Cell Therapy Products, Services and Solutions
7.5.4 Vcanbio Cell Therapy Revenue (US$ Million) & (2020-2025)
7.5.5 Vcanbio Recent Developments
7.6 Fujifilm Cellular Dynamics
7.6.1 Fujifilm Cellular Dynamics Profile
7.6.2 Fujifilm Cellular Dynamics Main Business
7.6.3 Fujifilm Cellular Dynamics Cell Therapy Products, Services and Solutions
7.6.4 Fujifilm Cellular Dynamics Cell Therapy Revenue (US$ Million) & (2020-2025)
7.6.5 Fujifilm Cellular Dynamics Recent Developments
7.7 JCR Pharmaceuticals
7.7.1 JCR Pharmaceuticals Profile
7.7.2 JCR Pharmaceuticals Main Business
7.7.3 JCR Pharmaceuticals Cell Therapy Products, Services and Solutions
7.7.4 JCR Pharmaceuticals Cell Therapy Revenue (US$ Million) & (2020-2025)
7.7.5 JCR Pharmaceuticals Recent Developments
7.8 Beike Biotechnology
7.8.1 Beike Biotechnology Profile
7.8.2 Beike Biotechnology Main Business
7.8.3 Beike Biotechnology Cell Therapy Products, Services and Solutions
7.8.4 Beike Biotechnology Cell Therapy Revenue (US$ Million) & (2020-2025)
7.8.5 Beike Biotechnology Recent Developments
7.9 Golden Meditech
7.9.1 Golden Meditech Profile
7.9.2 Golden Meditech Main Business
7.9.3 Golden Meditech Cell Therapy Products, Services and Solutions
7.9.4 Golden Meditech Cell Therapy Revenue (US$ Million) & (2020-2025)
7.9.5 Golden Meditech Recent Developments
7.10 Guanhao Biotech
7.10.1 Guanhao Biotech Profile
7.10.2 Guanhao Biotech Main Business
7.10.3 Guanhao Biotech Cell Therapy Products, Services and Solutions
7.10.4 Guanhao Biotech Cell Therapy Revenue (US$ Million) & (2020-2025)
7.10.5 Guanhao Biotech Recent Developments
8 Industry Chain Analysis
8.1 Cell Therapy Industrial Chain
8.2 Cell Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Cell Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Cell Therapy Market Trends
Table 2. Cell Therapy Market Drivers & Opportunity
Table 3. Cell Therapy Market Challenges
Table 4. Cell Therapy Market Restraints
Table 5. Global Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cell Therapy Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Cell Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell Therapy
Table 10. Global Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Cell Therapy Sales Market Share in Value by Type (2020-2025)
Table 17. Global Cell Therapy Sales Market Share in Value by Type (2026-2031)
Table 18. Global Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Cell Therapy Sales Market Share in Value by Application (2020-2025)
Table 22. Global Cell Therapy Sales Market Share in Value by Application (2026-2031)
Table 23. Global Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Cell Therapy Sales Value by Region (2020-2025) & (%)
Table 27. Global Cell Therapy Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Cell Therapy Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Cell Therapy Sales Value, (2026-2031) & (US$ Million)
Table 31. Gilead Sciences Basic Information List
Table 32. Gilead Sciences Description and Business Overview
Table 33. Gilead Sciences Cell Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cell Therapy Business of Gilead Sciences (2020-2025)
Table 35. Gilead Sciences Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis Cell Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell Therapy Business of Novartis (2020-2025)
Table 40. Novartis Recent Developments
Table 41. Osiris Basic Information List
Table 42. Osiris Description and Business Overview
Table 43. Osiris Cell Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell Therapy Business of Osiris (2020-2025)
Table 45. Osiris Recent Developments
Table 46. Vericel Corporation Basic Information List
Table 47. Vericel Corporation Description and Business Overview
Table 48. Vericel Corporation Cell Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell Therapy Business of Vericel Corporation (2020-2025)
Table 50. Vericel Corporation Recent Developments
Table 51. Vcanbio Basic Information List
Table 52. Vcanbio Description and Business Overview
Table 53. Vcanbio Cell Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell Therapy Business of Vcanbio (2020-2025)
Table 55. Vcanbio Recent Developments
Table 56. Fujifilm Cellular Dynamics Basic Information List
Table 57. Fujifilm Cellular Dynamics Description and Business Overview
Table 58. Fujifilm Cellular Dynamics Cell Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell Therapy Business of Fujifilm Cellular Dynamics (2020-2025)
Table 60. Fujifilm Cellular Dynamics Recent Developments
Table 61. JCR Pharmaceuticals Basic Information List
Table 62. JCR Pharmaceuticals Description and Business Overview
Table 63. JCR Pharmaceuticals Cell Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell Therapy Business of JCR Pharmaceuticals (2020-2025)
Table 65. JCR Pharmaceuticals Recent Developments
Table 66. Beike Biotechnology Basic Information List
Table 67. Beike Biotechnology Description and Business Overview
Table 68. Beike Biotechnology Cell Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell Therapy Business of Beike Biotechnology (2020-2025)
Table 70. Beike Biotechnology Recent Developments
Table 71. Golden Meditech Basic Information List
Table 72. Golden Meditech Description and Business Overview
Table 73. Golden Meditech Cell Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell Therapy Business of Golden Meditech (2020-2025)
Table 75. Golden Meditech Recent Developments
Table 76. Guanhao Biotech Basic Information List
Table 77. Guanhao Biotech Description and Business Overview
Table 78. Guanhao Biotech Cell Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell Therapy Business of Guanhao Biotech (2020-2025)
Table 80. Guanhao Biotech Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Cell Therapy Downstream Customers
Table 84. Cell Therapy Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts


List of Figures
Figure 1. Cell Therapy Product Picture
Figure 2. Global Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cell Therapy Sales Value (2020-2031) & (US$ Million)
Figure 4. Cell Therapy Report Years Considered
Figure 5. Global Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell Therapy Revenue in 2024
Figure 7. Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Stem Cell Picture
Figure 9. Non-Stem Cell Picture
Figure 10. Global Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Cell Therapy Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Global Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Cell Therapy Sales Value Market Share by Application, 2024 & 2031
Figure 16. North America Cell Therapy Sales Value (2020-2031) & (US$ Million)
Figure 17. North America Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 18. Europe Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 19. Europe Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 20. Asia Pacific Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 21. Asia Pacific Cell Therapy Sales Value by Region (%), 2024 VS 2031
Figure 22. South America Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 23. South America Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 24. Middle East & Africa Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 25. Middle East & Africa Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 26. Key Countries/Regions Cell Therapy Sales Value (%), (2020-2031)
Figure 27. United States Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 28. United States Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 29. United States Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 30. Europe Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 32. Europe Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 33. China Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 34. China Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 35. China Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 36. Japan Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 37. Japan Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 38. Japan Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 39. South Korea Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 40. South Korea Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 41. South Korea Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 42. Southeast Asia Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 44. Southeast Asia Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 45. India Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 46. India Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 47. India Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 48. Cell Therapy Industrial Chain
Figure 49. Cell Therapy Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed